Truvestments Capital LLC Insmed Inc Transaction History

Truvestments Capital LLC

$363 Million
Q3 2024

A detailed history of Truvestments Capital LLC transactions in Insmed Inc stock. As of the latest transaction made, Truvestments Capital LLC holds 84 shares of INSM stock, worth $5,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$5,568

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $5,208 - $6,636	84 New	84 $6,000
Q1 2023 May 12, 2023	SELL	$16.26 - $21.73 $894 - $1,195	-55 Reduced 39.57%	84 $1,000
Q2 2022 Aug 09, 2022	BUY	$17.07 - $25.71 $2,372 - $3,573	139 New	139 $3,000
Q1 2022 May 02, 2022	SELL	$20.42 - $28.13 $2,838 - $3,910	-139 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$32.28 - $44.3 $1,581 - $2,170	-49 Reduced 26.06%	139 $5,000
Q4 2020 Feb 17, 2021	BUY	$31.45 - $40.54 $5,912 - $7,621	188 New	188 $6,000
Q3 2020 Nov 13, 2020	SELL	$26.0 - $34.5 $4,888 - $6,486	-188 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$14.11 - $29.42 $2,652 - $5,530	188 New	188 $5,000
Q4 2019 Jan 29, 2020	SELL	$16.12 - $24.98 $5,319 - $8,243	-330 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$15.49 - $25.78 $604 - $1,005	-39 Reduced 10.57%	330 $6,000
Q1 2019 Apr 12, 2019	SELL	$13.91 - $31.15 $13 - $31	-1 Reduced 0.27%	369 $11,000
Q3 2018 Oct 22, 2018	BUY	$18.95 - $28.08 $7,011 - $10,389	370 New	370 $7,000

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$946 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$834 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$696 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$432 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account